| | 英文名称 | | 中文名称 | | CAS |
|---|---|---|
| PI4KIIIbeta-IN-9 | 1429624-84-9 | 1429624-84-9 |
| DC_517 | CS-2082 | 500017-70-9 |
| 2-[[3-(4-Morpholinyl)propyl]amino]-4-pyridinecarboxylic acid 2-[1-(4-chloro-2-hydroxyphenyl)propylidene]hydrazide | CS-2124 | 1395048-49-3 |
| Lp-PLA2 -IN-1 | 1420367-28-7 | 1420367-28-7 |
| Mirk-IN-1 | 1386979-55-0 | 1386979-55-0 |
| AlviMopan (Monohydrate) | 爱维莫潘水合物 | 1383577-62-5 |
| CAY10618 | CAY10618 | 1202580-59-3 |
| RIP2 kinase inhibitor 1 | RIP2 kinase inhibitor 1 | 1423186-80-4 |
| Btk inhibitor 1 | 1412418-47-3 | 1412418-47-3 |
| GQ-16 | GQ-16 | 870554-67-9 |
| D8-MMAE | 2070009-72-0 | 2070009-72-0 |
| TAT (48 - 57) | 穿膜肽TAT (48-57) | 253141-50-3 |
| AGA-(C8R) HNG17, Humanin derivative | PAGASRLLLLTGEIDLP | 875910-01-3 |
| JNJ31001074AAC | BAVISANT DIHYDROCHLORIDE HYDRATE | 1103522-80-0 |
| Piribedil-d8 | 吡贝地尔D8 | 1398044-45-5 |
| Necrostatin-2 S enantioMer | (5S)-5-[(7-氯-1H-吲哚-3-基)甲基]-3-甲基-2,4-咪唑烷二酮 | 852391-20-9 |
| GT 2016 | GT 2016 | 152241-24-2 |
| BMS-983970 | 1584713-87-0 | 1584713-87-0 |
| ALS-8176 | 化合物LUMICITABINE | 1445385-02-3 |
| Mutant IDH1 inhibitor | (4S)-3-[2-[[(1S)-1-[4-[(4-乙酰基-1-哌嗪基)甲基]苯基]乙基]氨基]-4-嘧啶基]-4-异丙基-2-恶唑烷酮 | 1429180-08-4 |
